The effect of prior tetanic stimulation on train-of-four monitoring in paediatric patients: A randomised open-label controlled trial
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Anaesthesiology"
DOI: 10.1097/eja.0000000000000558
Abstract: BACKGROUND In clinical research, neuromuscular monitoring must present a stable response for a period of 2 to 5 min before administration of a neuromuscular blocking agent. The time required to reach this stable response may be… read more here.
Keywords: trial; randomised open; stimulation; time ... See more keywords
A randomised, open‐label, parallel‐group, multicentre, comparative study to compare the efficacy and safety of Exufiber® with Aquacel® Extra™ dressings in exuding venous and mixed aetiology leg ulcers
Sign Up to like & getrecommendations! Published in 2022 at "International Wound Journal"
DOI: 10.1111/iwj.13913
Abstract: The performance and safety of Exufiber® gelling fibre and Aquacel® Extra™ Hydrofiber® wound dressings were compared for the management of chronic, exuding leg ulcers. The 6‐week study (≤ 24 weeks in a subgroup of subjects) was a… read more here.
Keywords: randomised open; aquacel extra; leg ulcers; exufiber aquacel ... See more keywords
Oral prednisolone for acute otitis media in children: protocol of a pilot randomised, open-label, controlled study (OPAL study)
Sign Up to like & getrecommendations! Published in 2018 at "Pilot and Feasibility Studies"
DOI: 10.1186/s40814-018-0337-x
Abstract: BackgroundAcute otitis media (AOM) is an acute inflammation of the middle ear commonly found in children, for which antibiotics are frequently prescribed. However, antibiotics are beneficial for only one third of AOM cases, and then,… read more here.
Keywords: otitis media; randomised open; study; pilot ... See more keywords
Nivolumab combined with high dose multisite radiotherapy in previously untreated advanced melanoma (NIRVANA): A non-randomised, open-label, multicenter, phase 2 trial.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e21505
Abstract: e21505 Background: Outcome of advanced melanoma remains poor for the majority of patients (pts) and new treatment strategies are needed. Preclinical and clinical data suggest a potential increase of the immunotherapy efficacy when combined with… read more here.
Keywords: randomised open; trial; multisite radiotherapy; melanoma ... See more keywords